Note: This document contains side effect information about methscopolamine. Some dosage forms listed on this page may not apply to the brand name Pamine.

Applies to methscopolamine: oral tablets.

Side effects include:

Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).

For Healthcare Professionals

Applies to methscopolamine: oral tablet.

Cardiovascular

Frequency not reported: Tachycardia, palpitation^[Ref]

Hypersensitivity

Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis^[Ref]

Nervous system

Frequency not reported: Headaches, drowsiness, dizziness, loss of taste^[Ref]

Ocular

Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension^[Ref]

Gastrointestinal

Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia^[Ref]

Dermatologic

Frequency not reported: Decreased sweating, urticaria and other dermal manifestations^[Ref]

Genitourinary

Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation^[Ref]

Other

Frequency not reported: Weakness^[Ref]

Psychiatric

Frequency not reported: Nervousness, mental confusion, insomnia^[Ref]